Dr. Goldstein comments on NY Times article on new Osteoporosis drug

In yesterday‘s New York Times, a teaser on the front page was entitled “Treatment for brittle bones”. The article itself was entitled “Osteoporosis drug deploys genetic tool to build bone”. On Tuesday the FDA approved a new drug known as Evenity (generic is romosozumab-aqqg). The article talks significantly about the fact that this is the first drug that restores bone without breaking it down. Understand that bone is a dynamic organ. It is constantly being laid down and taken away un...

New York Times Article on Funguses immune to drugs

  The lead article in yesterday‘s New York Times was entitled, “Fungus immune to drugs quietly sweeps the globe”…”Lethal infection adds alarming information to dangers of overusing medicine.”     For those of you who read the article there is no fear. This is a new species of the fungus Candida called Auris that is significant for people who have immune compromised systems, such as patients on chemotherapy, long-term steroid use, the very young and the very old. ...